FDA Seeks Public Views on Proposed 510(k) Plans

The FDA expects 'strong public interest' regarding IOM's recommendations to make big changes to device review processes.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories